MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1542/peds.2024-068280

Медицинская библиотека · Pediatrics · 2025

Respiratory and Other Infections Following COVID.

Allen Andrea J, Nguyen Nhat, Lorman Vitaly, Maltenfort Mitchell, Saleh Mohammad Mosa Abu, Sekar Anisha, Mejias Asuncion, Taylor Emily, Mendonca Eneida A, Nabower Aleisha M, Oxner Asa, Paules Catharine, Williams David A, Christakis Dimitri A, Sills Marion R, Jhaveri Ravi, Gonzalez Sandy, Blecker Saul, Suresh Srinivasan, Schuyler Jones W, Charles Bailey L, Cummins Mollie R, Chrischilles Elizabeth A, Forrest Christopher B, Rao Suchitra, RECOVER consortium

СтатьяПеревод в очереди

Аннотация

BACKGROUND

One hypothesis for the respiratory syncytial virus (RSV) surge in 2022 was suppression of immune responses following SARS-CoV-2 infection. Our objective was to compare the risk of subsequent RSV and other infections among children with and without SARS-CoV-2 infection.

METHODS

We conducted a retrospective cohort study using electronic health record data from 27 US health systems analyzing children aged under 5 years with SARS-CoV-2 infection (test/coded) between March and July 2022. The comparison groups were children with (a) influenza infection and (b) respiratory tract infection with no evidence of SARS-CoV-2/influenza infection. The primary and secondary outcomes were RSV infection and respiratory or any infection in the subsequent 15 to 180 days, respectively. We applied inverse probability of treatment weighting and performed weighted logistic regression modeling.

RESULTS

Our primary and secondary cohorts consisted of 18 767 and 114 414 children with SARS-CoV-2 infection, and 6697 and 30 424 with influenza infection, respectively, and 46 697 with another acute respiratory tract infection. The odds of subsequent RSV were lower in the SARS-CoV-2 group compared with the influenza group (adjusted odds ratio [aOR] 0.73, 95% CI 0.61-0.86) and compared with the group with any respiratory tract infection (aOR 0.78, 95% CI 0.7-0.87). The odds of a respiratory tract infection and any infection were lower in the SARS-CoV-2 group than the influenza group (aOR 0.62, 95% CI 0.59-0.64 and aOR 0.67, 95% CI 0.65-0.7, respectively).

CONCLUSIONS

We did not find an increased risk of RSV or a respiratory or any type of infection within 6 months of SARS-CoV-2 infection, compared with influenza and other respiratory illnesses.

Для цитирования: Allen Andrea J, Nguyen Nhat, Lorman Vitaly, Maltenfort Mitchell, Saleh Mohammad Mosa Abu, Sekar Anisha, Mejias Asuncion, Taylor Emily, Mendonca Eneida A, Nabower Aleisha M, Oxner Asa, Paules Catharine, Williams David A, Christakis Dimitri A, Sills Marion R, Jhaveri Ravi, Gonzalez Sandy, Blecker Saul, Suresh Srinivasan, Schuyler Jones W, Charles Bailey L, Cummins Mollie R, Chrischilles Elizabeth A, Forrest Christopher B, Rao Suchitra, RECOVER consortium. Respiratory and Other Infections Following COVID.. Pediatrics. 2025. DOI: 10.1542/peds.2024-068280.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.